Northwest Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,510
Closed -$216K 122
2024
Q4
$216K Sell
2,510
-377
-13% -$40.8K 0.18% 109
2024
Q3
$344K Sell
2,887
-14
-0.5% -$1.87K 0.27% 73
2024
Q2
$414K Buy
2,901
+181
+7% +$24K 0.42% 57
2024
Q1
$349K Buy
2,720
+277
+11% +$33K 0.38% 65
2023
Q4
$253K Buy
+2,443
New +$242K 0.21% 75

Other funds holding NVO

Northwest Financial Advisors's NVO Position: Q1 2025 in Review

Northwest Financial Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,510 shares — an estimated $216K sold.

Northwest Financial Advisors first reported a position in NVO in Q4 2023 and held it in 5 quarters. The position peaked at $414K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Northwest Financial Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Northwest Financial Advisors sold 2,510 Novo Nordisk shares in Q1 2025, an estimated $216K.
  • Northwest Financial Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 5 quarters.
  • Northwest Financial Advisors's Novo Nordisk position peaked at $414K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Northwest Financial Advisors's 13F filing for Q1 2025, filed 11 Apr 2025.